IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -2,136.5% | -1,635.2% | -4,756.6% | -1,551.9% | -1,101.2% | -547.1% | |
| – | – | – | – | – | – | 32.4% | 191.3% | 544.9% | 111.8% | 83.1% | 54.2% | |
| – | – | – | – | – | – | 416.6% | 311.2% | 1,048.2% | 437.3% | 101.7% | 54.7% | |
| – | – | – | – | – | – | 163.0% | 6.8% | -202.7% | -264.2% | -70.2% | 67.3% | |
| – | – | – | – | – | – | 100.9% | 102.2% | 453.0% | 18.7% | 27.4% | 78.5% | |
| – | – | – | – | – | – | -966.1% | -635.2% | -453.0% | -62.0% | -27.2% | -78.5% | |
| – | – | – | – | – | – | -1.2% | -10.9% | 0.0% | -74.4% | -286.5% | 0.0% | |
| – | – | – | – | – | – | – | -69.8% | -149.2% | -7.8% | -10.7% | -12.6% | |
| – | – | – | – | – | – | 1,874.9% | 3,565.2% | 3,737.6% | 810.8% | 1,086.1% | 692.3% | |
| – | – | – | – | – | – | -1,227.7% | 1,294.9% | -1,472.0% | -803.1% | -42.3% | 90.7% | |
| – | – | – | – | – | – | -2,237.4% | -1,737.4% | -5,209.6% | -1,570.6% | -1,128.6% | -625.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.